Pasireotide (SOM230) is effective for the treatment of pancreatic neuroendocrine tumors (PNETs) in a multiple endocrine neoplasia type 1 (MEN1) conditional knockout mouse model. (Q37066453)
Jump to navigation
Jump to search
scientific article published on 24 October 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | Pasireotide (SOM230) is effective for the treatment of pancreatic neuroendocrine tumors (PNETs) in a multiple endocrine neoplasia type 1 (MEN1) conditional knockout mouse model. |
scientific article published on 24 October 2012 |
Statements
Pasireotide (SOM230) is effective for the treatment of pancreatic neuroendocrine tumors (PNETs) in a multiple endocrine neoplasia type 1 (MEN1) conditional knockout mouse model (English)
Steven K Libutti
Ziqiang Yuan
Asha Adem
Rula Geha
Chakravarthy Vrikshajanani
Wade Koba
Eugene Fine
David T Hughes
Herbert A Schmid
24 October 2012
1 reference
1 reference
1 reference
1 reference
1 reference